Related Experiment Video
Updated: Jan 13, 2026

Spectrophotometric Methods for the Study of Eukaryotic Glycogen Metabolism
Published on: August 19, 2021
Novel α-amylolyzates derived from enzymatically synthesized α-glucans using diverse glycogen branching enzymes
Young-Bo Song1, Moon-Gi Hong2, Won-Min Lee1
1Department of Food Science & Biotechnology and Carbohydrate Bioproduct Research Center, Sejong University, Seoul, Republic of Korea.
Abstract:
In this study, the internal branched structure of highly branched α-glucans (HBαGs) was regulated by employing glycogen branching enzymes (GBEs) from different microbial sources and amylosucrase, with the purpose of synthesizing structurally diverse α-amylolyzates. Variations in GBE origin resulted in HBαGs with distinct fine structural features, including differences in α-1,6 branching degree and molecular weight. Following hydrolysis with Aspergillus oryzae α-amylase, the resulting α-amylolyzates exhibited a high degree of branching (from 26.6 to 30.9%) and large molecular weight (1.07 × 106 to 1.86 × 107 g mol-1) after removal of linear maltooligosaccharide region. These α-amylolyzates exhibit resistance to α-amylase due to their large molecular size and dense branching structure, and therefore can be hydrolyzed into glucose only by mucosal α-glucosidase complexes, notably from rat intestinal and recombinant human sources. As a result, various tailor-made α-amylolyzate samples, specifically designed based on different HBαGs, showed a significant reduction in the glucose generation rate. This study presents various enzymatic strategies for producing structurally diverse α-amylolyzates, which are slowly degraded in digestive enzymes. These materials extend the region of glucose release and absorption within the small intestine, thereby attenuating glycemic responses and suggesting their potential as functional ingredients for regulating glucose homeostasis.
Related Concept Videos
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
Acarbose and miglitol are...
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
Hormones Regulating Blood Glucose
In addition to accelerating glucose uptake and utilization, insulin has...
Carbohydrate Digestion
Oral Hypoglycemic Agents: Glinides
Biosynthesis of Polysaccharides

